~" To determine if leukotrienes are important mediators of vascular permeability in brain tumors, the effect of 5-1ipoxygenase inhibitors on blood-tumor barrier permeability in rats harboring HK Walker 256 brain tumors was examined using quantitative autoradiography with a-~4C-aminoisobutyric acid. The 5-1ipoxygenase enzyme converts arachidonic acid to leukotrienes. Three 5-1ipoxygenase inhibitors were utilized: BW755C, nordihydroguaiaretic acid, and AA-861. All three 5-1ipoxygenase inhibitors significantly decreased vascular permeability both within the tumors and in brain adjacent to tumor. This suggests that capillary permeability in and adjacent to ~umors is influenced by endogenous leukotrienes and that leukotfienes pIay an important role in brain tumor edema.
W
E have demonstrated previously that leukotrienes C4 (LTC4) infused into the carotid artery ipsilateral to an experimental glial tumor will increase the unidirectional transfer constant for permeability (K~) within the tumor twofold, while no effect on permeability is seen in normal brain. 7 Intracarotid infusion of LTC4 also selectively increases blood-brain barrier (BBB) permeability within ischemic brain tissue in rats) A significant correlation between vasogenic brain edema surrounding brain tumors and LTC4 levels in tumor tissue has been shown, 6 as well as high-affinity binding sites for LTC4 on isolated brain capillaries. 3 These observations have led us and others to speculate that leukotfienes could be important mediators of capillary permeability in pathological conditions in which the ability of brain capillaries to inactivate LTC4 is impaired.
Since leukotrienes are oxidized products of amchidonic acid through the 5-1ipoxygenase pathway, we sought in this study to determine whether inhibition of the 5-1ipoxygenase enzyme would decrease BBB permeability in brain tumors. The inhibitory agent BW-755C primarily acts on 5-1ipoxygenase but also has some effects on cyclo-oxygenase, which metabolizes arachidonic acid to prostaglandinsJ J,~4 Nordihydroguaiaretic acid (NDGA) ~0 and AA-86112,16,26 selectively inhibit 5-1ipoxygenase but not cyclo-oxygenase. Here we report on the effects of these three 5-1ipoxygenase inhibitors on the blood-tumor barrier permeability in rats harboring HK Walker 256 brain tumors and discuss the biological implications.
Materials and Methods
Twenty-eight female Wistar rats, each weighing 110 to 150 gin, were used for this study. Prior to intraperitoneal administration in the rats, BW755C, NDGA, and AA-861" were dissolved in cottonseed oil and prepared as an emulsion (10% oil) in 0.8% polyoxyethylene sorbitan mono-oleate (Tween 80) phosphate-buffered saline (PBS). Alpha-[ 1-~4C]-aminoisobutyric acid (AIB) (50.0 mCi/mmol)t was used for quantitative autoradiographic studies.
Tumor Inoculation
The HK Walker 256 tumor cells were maintained in F-12 medium with 10% calf serum.~ The rats were anesthetized with intraperitoneal pentobarbital sodium (Nembutal, 40 mg/kg). Tumor cells (5 x 105 in a 5-~1 solution) were stereotactically injected by means of a Hamilton syringe into the fight cerebral hemisphere through a burr hole 5 mm lateral to the bregma and 5 mm vertically deep to the dural surface.
5-Lipoxygenase Experiments
The rats were divided into four groups and given * BW755C was a gift from Wencome Reagents Ltd., Beckenham, England; NDGA was supplied by Sigma Chemical Co., St. Louis, Missouri; AA-861 was a gift from Takeda Medical Co., Osaka, Japan.
t Alpha-[1-~4C]-aminoisobutyric acid supplied by New England Nuclear, Boston, Massachusetts.
~t F-12 medium and 10% calf serum obtained from GIBCO, Grand Island, New York. intraperitoneal injections of either BW755C (10 mg/ kg), NDGA (1.2 mg/kg), AA-861 (20 mg/kg), or cottonseed oil (10%) emulsion in 0.8% Tween 80 PBS (vehicle control). The injections were administered every 8 hours beginning 3 days after tumor implantation. Six days after tumor implantation and 2 to 4 hours after the last intraperitoneal drug administration, the rats were again anesthetized and both femoral arteries and one femoral vein were cannulated. Body temperature was maintained at 37~ and arterial blood gas levels, blood pressure, and hematocrit were monitored. Animals with abnormal physiological parameters were eliminated from the study. An intravenous bolus of ~4C-AIB (100 uCi/kg) was injected, and a peristaltic withdrawal pumpw was used to obtain femoral arterial blood at a constant rate of 0.083 ml/min immediately after injection of ~4C-AIB for determination of serum radioactivity. Ten minutes after the injection of ~4C-AIB, the animals were killed by decapitation and the brains were rapidly removed and frozen.
A utoradiography
The frozen rat brains were mounted onto pedestals with M-1 embedding matrix, l[ and 20-urn coronal sections were cut using a cryotome. The sections were thaw-mounted onto coverslips and autoradiograms were generated by coexposing the sections on Kodak XAR-5 film with tissue-calibrated 14C standards* for 2 weeks. After exposure, the sections were stained with hematoxylin and eosin to correlate areas of histologically verified tumor with autoradiograms. Quantitative analysis was performed using a computer-assisted digital image analyzer. TM A unidirectional blood-to-brain transfer constant (K~) was calculated using the method of Blasberg, et al.,S and was expressed in ul/gm/min.
Definition of Regions
For K~ measurements, the tumor periphery was defined as the outer half of the tumor radius, the tumor center as the inner half of the tumor radius, and brain adjacent to tumor as an area of the adjacent basal ganglia in the vascular territory of the lenticular striate vessels.
Data Analysis
The Ki values for the experiments were calculated by measuring the three regions of interest described above in three consecutive sections. T. Baba, C. C. Chio, and K. L. Black
Results

Physiological Status
Arterial blood gas levels were measured in all rats used in the experiments. The mean pH, PaCO2, and PaO2 were 7.432 __ 0.028, 38.4 _+ 3.6 mm Hg, and 108.2 _+ 19.1 mm Hg, respectively. The mean arterial blood pressure was 109.4 + 9.2 mm Hg and hematocrit was 32.6% _+ 3.9%. There was no statistically significant difference in these physiological parameters among the four rat groups.
Brain Tumor Size
The size of the rat brain tumors was measured in the section with the largest tumor area. The average size was 7.9 _ 2.7 sq mm, and there was no statistically significant difference among the four rat groups.
BBB Permeability
The mean BBB permeability (Ki) in the seven rats in the control group was 300.9 + 87.7 #l/gin/rain in the tumor center, 212.9 _ 60.1 tA/gm/min at the tumor periphery, and 45.1 + 12.1 ul/gm/min in brain adjacent to tumor. Administration of BW755C decreased the mean Ka value to 174.9 __ 79.2, 98.7 _+ 35.2, and 22.3 _ 8.0 ~l/gm/min in the tumor center, tumor periphery, and brain adjacent to tumor, respectively. These changes were all significant compared to the control group (p < 0.005, p < 0.001, and p < 0.001, respectively). A mean significant decrease in the Ki value after NDGA administration was also noted compared to the control group (173.3 _+ 39. tumor periphery, and brain adjacent to tumor, respectively. These differences were also statistically significant compared to the control group (p < 0.05, p < 0.005, and p < 0.005, respectively). The mean K~ value in the extratumoral normal tissue of the control group was 3.8 + 4.0 gl/gm/min in the ipsilateral frontal cortex, 3.8 _+ 4.0 ul/gm/min in the contralateral frontal cortex, 3.8 _+ 4.0 ul/gm/min in the ipsilateral basal ganglia, and 4.2 _ 3.7 #l/gm/min in the contralateral basal ganglia. These mean values were 2.2 _+ 2.9, 3.1 _+ 3.0, 4.6 + 5.4, and 3.1 + 3.0 ~d/gm/min, respectively, in the BW-755C-treated group; 1.1 _+ 2.9, 1.1 + 2.9, 2.5 _+ 3.3, and 1.1 _ 2.9 ul/gm/min, respectively, in the NDGAtreated group; and 2.2 + 3.3, 2.2 + 3.3, 2.9 + 3.6, and 2.6 +_ 3.3 ul/gm/min, respectively, in the AA-861-treated group. There were no significant differences among these groups. These data are summarized in Fig. 1 . We also demonstrated that LTC4 infused into the carotid artery ipsilateral to experimental glial tumors in rats could selectively increase permeability within the tumor twofold, without increasing permeability in normal brain. 7 However, LTC4 markedly increases vascular permeability in a variety of systemic capillary beds. ~5.t9 Normal brain capillaries, unlike systemic capillaries, appear to resist the vasoactive effects of leukotrienes.
Discussion
Gamma Glutamyl Transpeptidase
Gamma glutamyl transpeptidase ('r-GTP) is an enzyme that inactivates LTC4 to LTD4 and LTE4 to LTF4.1 Both 7-GTP and aminodipeptidase (an enzyme that inactivates LTD4 to LTE4) are enzymes unique to brain capillaries and are not present in systemic capillaries. 9 Unlike normal brain capillaries, which are rich in 7-GTP, tumor capillaries appear to lack -r-GTP. This led us to speculate that normal brain capillaries might use "r-GTP as an enzymatic barrier to inactivate LTC4, which is a potent mediator of vascular permeability in systemic capillaries, capillaries that lack 3,-GTP. Interestingly, LTC4 slightly increased BBB permeability in brain adjacent to tumors where 7-GTP was also moderately decreased. 7 Recently, we have demonstrated that the BBB could be selectively opened by intracarotid infusions of LTC4 in ischemic tissue 48 to 72 hours after middle cerebral artery occlusion, but it could not be opened in ischemic tissue 24 hours after middle cerebral artery occlusion) We suggested this was due to loss of 7-GTP in ischemic capillaries over time. Almost all 7-GTP activity in brain capillaries is lost in ischemic tissue by 72 hours after occlusion; however, moderate amounts of 7-GTP activity still remain in capillaries of ischemic tissue 24 hours after occlusion)
Leukotrienes and Edema
In the present study, we demonstrated that inhibitors of 5-1ipoxygenase will decrease permeability within brain tumors and in brain tissue adjacent to tumors. This suggests that capillary permeability within and adjacent to brain tumors is, at least in part, related to levels ofendogenous leukotrienes. After cerebral injury, the leukotriene content is increased. 6''3 Increased levels of leukotrienes coupled with increased susceptibility to their vasoactive effects suggest that leukotrienes might play an important role in vasogenic edema in pathological lesions.
Unterberg, et al., 2~ reported that arachidonic acid itself and not its degeneration products are responsible for the induction of barrier opening, and concluded that leukotrienes do not promote brain edema or act as mediators of cerebral edema.: ~ Their conclusion is based mainly on their examination of normal brain tissue, where the enzymatic barrier is intact and protecting brain tissue from the vasoactive effects of leukotrienes. Recently, however, they reported that BW755C did not affect brain edema in the cold-induced injury of rabbit brains) 2 Cold-induced injury is a severe form of capillary injury which results in mechanical destruction of brain capillaries. Cold injury is a poor model, therefore, to study how biochemical mediators might influence capillary permeability in pathological conditions such as tumors or ischemia. Their evidence against leukotrienes as mediators of brain edema is true primarily in normal brain tissue where enzymatic bartier is intact. In the pathological conditions that occur clinically, if the enzymatic barrier is damaged, we speculate that leukotrienes are one of perhaps many mediators that influence brain edema.
